GraftCraft AB is a small Swedish company, founded and mainly owned by Erney Mattsson, MD, PhD who currently acts as professor of vascular surgery at St Olav’s Hospital, Trondheim Norway and Torbjörn Lundh, PhD, professor of Mathematics at Chalmers University of Technology, Gothenburg Sweden.
The company combines competences within vascular surgery, business and product development, medical technology optimization, intellectual property strategies and in vitro- and in vivo studies.
GraftCraft’s mission is to provide doctors and their patients with novel, life-improving cardiovascular solutions. The company is currently developing two different devices in order to fulfil the mission; Unravelling Stent and ErneyGraft. The devices are all solving problems connected to common cardiovascular diseases.
GraftCraft has gained substantial economic support from the Swedish State, through VINNOVA, Sahlgrenska Science Park and Smart Textiles, and has been recognized as a new actor to build global business with a base in Western Sweden. GraftCraft is open to the possibility of cooperations with mutual benefits.